Digikare
Digikare is a French healthcare technology company focused on orthopedic and trauma surgery care pathways.
Profile
Digital platform that guides orthopedic surgery patients through recovery while collecting outcome data for clinicians.
Digikare is a French healthcare technology company focused on orthopedic and trauma surgery care pathways. Founded in the early 2020s, the company developed Orthense, a digital platform that automates patient guidance through post-operative recovery while collecting outcome data for clinicians. The solution targets private practices and hospitals seeking to reduce administrative burdens in follow-up care while improving patient adherence.
As of 2025, Digikare reports adoption by over 100 healthcare facilities in France, including a partnership with RENACOT (National Network of Orthopedic and Trauma Surgery Centers) endorsed by France's National Professional Council of Orthopedic Surgery. The platform's value proposition centers on automating routine patient communications while generating structured outcome data that clinicians can use for research publications or benchmarking against peer institutions. Financial disclosures are not public, but the RENACOT institutional partnership suggests growing traction in France's socialized healthcare system.
Who buys this
- Private orthopedic surgery practices
- Hospital orthopedic departments
- Trauma surgery centers
- Academic medical centers conducting outcome research
- National healthcare networks (e.g., RENACOT)
Strengths and what to watch
Strengths
- Institutional validation through RENACOT partnership with France's orthopedic professional council
- Claims 30-second setup for personalized patient care pathways
- Generates research-grade outcome data compatible with statistical tools like SPSS
Watch for
- Heavy reliance on French healthcare system partnerships with unclear international scalability
- No disclosed revenue model or pricing transparency for individual practices
- Potential data privacy complexities under EU medical device regulations
Key Information
- Founded
- 2020
Frequently Asked Questions
What is Digikare used for in orthopedic care?
Digikare's Orthense platform guides patients through post-surgical recovery while automatically collecting outcome data for clinicians. It serves French hospitals and private practices, automating follow-up care and generating research-grade metrics. The system partners with RENACOT to standardize recovery pathways across 100+ facilities.
How does Digikare help with orthopedic patient recovery?
The platform provides personalized post-op guidance to improve adherence, reducing administrative burdens. It structures recovery milestones and collects patient-reported outcomes. Clinicians access aggregated data for benchmarking against peer institutions, supporting evidence-based care adjustments during the rehabilitation process.
What makes Digikare different from other recovery platforms?
Digikare uniquely combines 30-second pathway setup with institutional validation from France's orthopedic council. Its RENACOT partnership ensures clinically vetted protocols. The system exports SPSS-compatible datasets, bridging patient care and academic research—a dual focus uncommon in commercial recovery tools.
Is Digikare only available in France?
Currently focused on the French market, Digikare's adoption spans 100+ facilities including RENACOT centers. While designed for France's socialized healthcare system, the platform's data architecture could support expansion. No disclosed international deployments exist as of 2025.
How does Digikare handle patient data privacy?
As an EU-based medical platform, Digikare complies with GDPR and medical device regulations. The system anonymizes outcome data for research while maintaining individual treatment records. However, specific compliance certifications aren't publicly detailed, requiring direct vendor consultation for privacy protocol verification.
Can small orthopedic practices use Digikare?
Yes, Digikare serves both private practices and hospitals, claiming rapid onboarding. However, pricing isn't transparently published—potential adopters must engage sales. The platform's value increases for practices contributing to RENACOT's national benchmarks or those publishing outcome research.
Sources
- digikare.com — Company overview and product capabilities
- digikare.com — Product interface examples
- digikare.com — RENACOT partnership validation
- meetings-eu1.hubspot.com — Commercial engagement model